Recent Updates
Recently added Catalysts
CELC Positive Sentiment

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call

Wednesday, March 20, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Celcuity Inc. has announced the release of its financial results for the fourth quarter and full year 2023. This event is scheduled to take place on March 27, 2024, after market close. Additionally, the company will host a webcast/teleconference at 4:30 p.m. ET to discuss these results and offer a corporate update. This engagement highlights Celcuity's commitment to maintaining communication with its investors and stakeholders.
Price reaction · baseline $18 (2024-03-19 close) · hit after-hours · clean, no other CELC news in the window
day 0 close · peak
-1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Celcuity is set to release its financial results, indicating transparency.
  • Management will host a webcast to discuss results and provide updates.
  • Scheduled events reflect proactive engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+27%
120-day peak, hindsight
Typical move
14.9%
average across 6 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
Gedatolisib
Phase 3 · Breast Cancer

Full Press Release Details

MINNEAPOLIS, March 20, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth quarter and full year 2023 after the market closes on Wednesday, March 27, 2024. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Webcast and Conference Call Information
To participate in the teleconference, domestic callers should dial 1-888-886-7786 or 1-416-764-8658. A live webcast presentation can also be accessed using this weblink:
https://viavid.webcasts.com/starthere.jsp?ei=1655995&tp_key=04c7a07803. A replay of the webcast will be available on the Celcuity website following the live event.

Frequently Asked Questions

When will Celcuity release its financial results?

Celcuity will release its financial results on March 27, 2024.

What time is the conference call on March 27?

The conference call will occur at 4:30 p.m. Eastern Time.

How can I participate in the teleconference?

Dial 1-888-886-7786 or 1-416-764-8658 to participate in the teleconference.

Where can I access the live webcast?

The live webcast can be accessed at the provided Viavid link.

Will there be a replay of the webcast?

Yes, a replay will be available on the Celcuity website after the event.

ShareAdd on Google
Tags: CELC Viatris Investor Conferences Healthcare Celcuity financial results 2023 Q4 biotechnology
Last updated: Mar 20, 2024

Biotech snapshot

Cash runway
$754M liquidity · $18M/mo burn
~41 mo
Minimal dilution risk
Lead asset
GedatolisibPhase 3
Breast Cancer →

Catalyst track record

+27%
best trade around CELC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CELC.

See every catalyst's timing & PoA →